The global Osteoarthritis Drugs market is projected to grow from US$ 9599.7 million in 2024 to US$ 11730 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Osteoarthritis Drugs Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

Report Covers:

This report presents an overview of global market for Osteoarthritis Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Osteoarthritis Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Osteoarthritis Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Osteoarthritis Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Osteoarthritis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Osteoarthritis Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Osteoarthritis Drugs Market Report

Report Metric	Details
Report Name	Osteoarthritis Drugs Market
Accounted market size in 2024	US$ 9599.7 in million
Forecasted market size in 2030	US$ 11730 million
CAGR	3.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Oral Injection External
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Osteoarthritis Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Osteoarthritis Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Drugs Market growing?

Ans: The Osteoarthritis Drugs Market witnessing a CAGR of 3.4 during the forecast period 2025-2030.

What is the Osteoarthritis Drugs Market size in 2030?

Ans: The Osteoarthritis Drugs Market size in 2030 will be US$ 11730 million.

What is the Osteoarthritis Drugs Market share by region?

Ans: Europe is follower, accounting for about 27% market share.

What is the market share of major companies in Osteoarthritis Drugs Market?

Ans: Top 5 companies occupied about 66% market share.

Who are the main players in the Osteoarthritis Drugs Market report?

Ans: The main players in the Osteoarthritis Drugs Market are Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics

What are the Application segmentation covered in the Osteoarthritis Drugs Market report?

Ans: The Applications covered in the Osteoarthritis Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Osteoarthritis Drugs Market report?

Ans: The Types covered in the Osteoarthritis Drugs Market report are Oral, Injection, External

1 Study Coverage

1.1 Osteoarthritis Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Osteoarthritis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market by Application

1.3.1 Global Osteoarthritis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Osteoarthritis Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Osteoarthritis Drugs Revenue by Region

2.2.1 Global Osteoarthritis Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Osteoarthritis Drugs Revenue by Region (2019-2024)

2.2.3 Global Osteoarthritis Drugs Revenue by Region (2025-2030)

2.2.4 Global Osteoarthritis Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Osteoarthritis Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Osteoarthritis Drugs Sales by Region

2.4.1 Global Osteoarthritis Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Osteoarthritis Drugs Sales by Region (2019-2024)

2.4.3 Global Osteoarthritis Drugs Sales by Region (2025-2030)

2.4.4 Global Osteoarthritis Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Osteoarthritis Drugs Sales by Manufacturers

3.1.1 Global Osteoarthritis Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Drugs in 2023

3.2 Global Osteoarthritis Drugs Revenue by Manufacturers

3.2.1 Global Osteoarthritis Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Drugs Revenue in 2023

3.3 Global Key Players of Osteoarthritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Osteoarthritis Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Osteoarthritis Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Osteoarthritis Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Osteoarthritis Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Osteoarthritis Drugs Sales by Type

4.1.1 Global Osteoarthritis Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Osteoarthritis Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

4.2 Global Osteoarthritis Drugs Revenue by Type

4.2.1 Global Osteoarthritis Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Osteoarthritis Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Osteoarthritis Drugs Price by Type

4.3.1 Global Osteoarthritis Drugs Price by Type (2019-2024)

4.3.2 Global Osteoarthritis Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Osteoarthritis Drugs Sales by Application

5.1.1 Global Osteoarthritis Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Osteoarthritis Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

5.2 Global Osteoarthritis Drugs Revenue by Application

5.2.1 Global Osteoarthritis Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Osteoarthritis Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Osteoarthritis Drugs Price by Application

5.3.1 Global Osteoarthritis Drugs Price by Application (2019-2024)

5.3.2 Global Osteoarthritis Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Osteoarthritis Drugs Market Size by Type

6.1.1 US & Canada Osteoarthritis Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Osteoarthritis Drugs Revenue by Type (2019-2030)

6.2 US & Canada Osteoarthritis Drugs Market Size by Application

6.2.1 US & Canada Osteoarthritis Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Osteoarthritis Drugs Revenue by Application (2019-2030)

6.3 US & Canada Osteoarthritis Drugs Market Size by Country

6.3.1 US & Canada Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Osteoarthritis Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Osteoarthritis Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Osteoarthritis Drugs Market Size by Type

7.1.1 Europe Osteoarthritis Drugs Sales by Type (2019-2030)

7.1.2 Europe Osteoarthritis Drugs Revenue by Type (2019-2030)

7.2 Europe Osteoarthritis Drugs Market Size by Application

7.2.1 Europe Osteoarthritis Drugs Sales by Application (2019-2030)

7.2.2 Europe Osteoarthritis Drugs Revenue by Application (2019-2030)

7.3 Europe Osteoarthritis Drugs Market Size by Country

7.3.1 Europe Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Osteoarthritis Drugs Sales by Country (2019-2030)

7.3.3 Europe Osteoarthritis Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Osteoarthritis Drugs Market Size

8.1.1 China Osteoarthritis Drugs Sales (2019-2030)

8.1.2 China Osteoarthritis Drugs Revenue (2019-2030)

8.2 China Osteoarthritis Drugs Market Size by Application

8.2.1 China Osteoarthritis Drugs Sales by Application (2019-2030)

8.2.2 China Osteoarthritis Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Osteoarthritis Drugs Market Size by Type

9.1.1 Asia Osteoarthritis Drugs Sales by Type (2019-2030)

9.1.2 Asia Osteoarthritis Drugs Revenue by Type (2019-2030)

9.2 Asia Osteoarthritis Drugs Market Size by Application

9.2.1 Asia Osteoarthritis Drugs Sales by Application (2019-2030)

9.2.2 Asia Osteoarthritis Drugs Revenue by Application (2019-2030)

9.3 Asia Osteoarthritis Drugs Sales by Region

9.3.1 Asia Osteoarthritis Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Osteoarthritis Drugs Revenue by Region (2019-2030)

9.3.3 Asia Osteoarthritis Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Osteoarthritis Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Osteoarthritis Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Information

11.1.2 Johnson & Johnson Overview

11.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Johnson & Johnson Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Johnson & Johnson Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Overview

11.2.3 Pfizer Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Pfizer Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer Recent Developments

11.3 Eli Lilly

11.3.1 Eli Lilly Company Information

11.3.2 Eli Lilly Overview

11.3.3 Eli Lilly Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Eli Lilly Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Eli Lilly Recent Developments

11.4 Abbott

11.4.1 Abbott Company Information

11.4.2 Abbott Overview

11.4.3 Abbott Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Abbott Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Abbott Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Information

11.5.2 GlaxoSmithKline Overview

11.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 GlaxoSmithKline Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GlaxoSmithKline Recent Developments

11.6 Sanofi

11.6.1 Sanofi Company Information

11.6.2 Sanofi Overview

11.6.3 Sanofi Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Sanofi Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Sanofi Recent Developments

11.7 Flexion Therapeutics

11.7.1 Flexion Therapeutics Company Information

11.7.2 Flexion Therapeutics Overview

11.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Flexion Therapeutics Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Flexion Therapeutics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Osteoarthritis Drugs Industry Chain Analysis

12.2 Osteoarthritis Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Osteoarthritis Drugs Production Mode & Process

12.4 Osteoarthritis Drugs Sales and Marketing

12.4.1 Osteoarthritis Drugs Sales Channels

12.4.2 Osteoarthritis Drugs Distributors

12.5 Osteoarthritis Drugs Customers

13 Market Dynamics

13.1 Osteoarthritis Drugs Industry Trends

13.2 Osteoarthritis Drugs Market Drivers

13.3 Osteoarthritis Drugs Market Challenges

13.4 Osteoarthritis Drugs Market Restraints

14 Key Findings in The Global Osteoarthritis Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Osteoarthritis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Oral

Table 3. Major Manufacturers of Injection

Table 4. Major Manufacturers of External

Table 5. Global Osteoarthritis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Osteoarthritis Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Osteoarthritis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Osteoarthritis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Osteoarthritis Drugs Revenue Market Share by Region (2019-2024)

Table 10. Global Osteoarthritis Drugs Revenue Market Share by Region (2025-2030)

Table 11. Global Osteoarthritis Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Osteoarthritis Drugs Sales by Region (2019-2024) & (MT)

Table 13. Global Osteoarthritis Drugs Sales by Region (2025-2030) & (MT)

Table 14. Global Osteoarthritis Drugs Sales Market Share by Region (2019-2024)

Table 15. Global Osteoarthritis Drugs Sales Market Share by Region (2025-2030)

Table 16. Global Osteoarthritis Drugs Sales by Manufacturers (2019-2024) & (MT)

Table 17. Global Osteoarthritis Drugs Sales Share by Manufacturers (2019-2024)

Table 18. Global Osteoarthritis Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Osteoarthritis Drugs Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Osteoarthritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Osteoarthritis Drugs Price by Manufacturers 2019-2024 (USD/Kg)

Table 22. Global Osteoarthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Drugs as of 2023)

Table 24. Global Key Manufacturers of Osteoarthritis Drugs, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Osteoarthritis Drugs, Product Offered and Application

Table 26. Global Key Manufacturers of Osteoarthritis Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 29. Global Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 30. Global Osteoarthritis Drugs Sales Share by Type (2019-2024)

Table 31. Global Osteoarthritis Drugs Sales Share by Type (2025-2030)

Table 32. Global Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Osteoarthritis Drugs Revenue Share by Type (2019-2024)

Table 35. Global Osteoarthritis Drugs Revenue Share by Type (2025-2030)

Table 36. Osteoarthritis Drugs Price by Type (2019-2024) & (USD/Kg)

Table 37. Global Osteoarthritis Drugs Price Forecast by Type (2025-2030) & (USD/Kg)

Table 38. Global Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 39. Global Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 40. Global Osteoarthritis Drugs Sales Share by Application (2019-2024)

Table 41. Global Osteoarthritis Drugs Sales Share by Application (2025-2030)

Table 42. Global Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Osteoarthritis Drugs Revenue Share by Application (2019-2024)

Table 45. Global Osteoarthritis Drugs Revenue Share by Application (2025-2030)

Table 46. Osteoarthritis Drugs Price by Application (2019-2024) & (USD/Kg)

Table 47. Global Osteoarthritis Drugs Price Forecast by Application (2025-2030) & (USD/Kg)

Table 48. US & Canada Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 49. US & Canada Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 50. US & Canada Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 53. US & Canada Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 54. US & Canada Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Osteoarthritis Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 60. US & Canada Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 61. Europe Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 62. Europe Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 63. Europe Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 66. Europe Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 67. Europe Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Osteoarthritis Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 73. Europe Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 74. China Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 75. China Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 76. China Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 79. China Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 80. China Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 83. Asia Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 84. Asia Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 87. Asia Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 88. Asia Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Osteoarthritis Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Osteoarthritis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Osteoarthritis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Osteoarthritis Drugs Sales by Region (2019-2024) & (MT)

Table 94. Asia Osteoarthritis Drugs Sales by Region (2025-2030) & (MT)

Table 95. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Type (2019-2024) & (MT)

Table 96. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Type (2025-2030) & (MT)

Table 97. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Application (2019-2024) & (MT)

Table 100. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Application (2025-2030) & (MT)

Table 101. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 107. Middle East, Africa and Latin America Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 108. Johnson & Johnson Company Information

Table 109. Johnson & Johnson Description and Major Businesses

Table 110. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 111. Johnson & Johnson Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Johnson & Johnson Recent Developments

Table 113. Pfizer Company Information

Table 114. Pfizer Description and Major Businesses

Table 115. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 116. Pfizer Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Pfizer Recent Developments

Table 118. Eli Lilly Company Information

Table 119. Eli Lilly Description and Major Businesses

Table 120. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 121. Eli Lilly Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Eli Lilly Recent Developments

Table 123. Abbott Company Information

Table 124. Abbott Description and Major Businesses

Table 125. Abbott Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 126. Abbott Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Abbott Recent Developments

Table 128. GlaxoSmithKline Company Information

Table 129. GlaxoSmithKline Description and Major Businesses

Table 130. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 131. GlaxoSmithKline Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. GlaxoSmithKline Recent Developments

Table 133. Sanofi Company Information

Table 134. Sanofi Description and Major Businesses

Table 135. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 136. Sanofi Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Sanofi Recent Developments

Table 138. Flexion Therapeutics Company Information

Table 139. Flexion Therapeutics Description and Major Businesses

Table 140. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 141. Flexion Therapeutics Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Flexion Therapeutics Recent Developments

Table 143. Key Raw Materials Lists

Table 144. Raw Materials Key Suppliers Lists

Table 145. Osteoarthritis Drugs Distributors List

Table 146. Osteoarthritis Drugs Customers List

Table 147. Osteoarthritis Drugs Market Trends

Table 148. Osteoarthritis Drugs Market Drivers

Table 149. Osteoarthritis Drugs Market Challenges

Table 150. Osteoarthritis Drugs Market Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Osteoarthritis Drugs Product Picture

Figure 2. Global Osteoarthritis Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Osteoarthritis Drugs Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Injection Product Picture

Figure 6. External Product Picture

Figure 7. Global Osteoarthritis Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Osteoarthritis Drugs Market Share by Application in 2023 & 2030

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Online Pharmacies

Figure 12. Osteoarthritis Drugs Report Years Considered

Figure 13. Global Osteoarthritis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Osteoarthritis Drugs Revenue 2019-2030 (US$ Million)

Figure 15. Global Osteoarthritis Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Osteoarthritis Drugs Revenue Market Share by Region (2019-2030)

Figure 17. Global Osteoarthritis Drugs Sales 2019-2030 ((MT)

Figure 18. Global Osteoarthritis Drugs Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Osteoarthritis Drugs Sales YoY (2019-2030) & (MT)

Figure 20. US & Canada Osteoarthritis Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Osteoarthritis Drugs Sales YoY (2019-2030) & (MT)

Figure 22. Europe Osteoarthritis Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Osteoarthritis Drugs Sales YoY (2019-2030) & (MT)

Figure 24. China Osteoarthritis Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Osteoarthritis Drugs Sales YoY (2019-2030) & (MT)

Figure 26. Asia (excluding China) Osteoarthritis Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Osteoarthritis Drugs Sales YoY (2019-2030) & (MT)

Figure 28. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Osteoarthritis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Drugs in the World: Market Share by Osteoarthritis Drugs Revenue in 2023

Figure 31. Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 33. Global Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 34. Global Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 35. Global Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Osteoarthritis Drugs Revenue Share by Country (2019-2030)

Figure 41. US & Canada Osteoarthritis Drugs Sales Share by Country (2019-2030)

Figure 42. U.S. Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 45. Europe Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 46. Europe Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 47. Europe Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 48. Europe Osteoarthritis Drugs Revenue Share by Country (2019-2030)

Figure 49. Europe Osteoarthritis Drugs Sales Share by Country (2019-2030)

Figure 50. Germany Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 51. France Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. China Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 56. China Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 57. China Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 58. China Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 59. Asia Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 60. Asia Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 61. Asia Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 62. Asia Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 63. Asia Osteoarthritis Drugs Revenue Share by Region (2019-2030)

Figure 64. Asia Osteoarthritis Drugs Sales Share by Region (2019-2030)

Figure 65. Japan Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. India Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Osteoarthritis Drugs Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Osteoarthritis Drugs Sales Share by Country (2019-2030)

Figure 76. Brazil Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Osteoarthritis Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Osteoarthritis Drugs Value Chain

Figure 82. Osteoarthritis Drugs Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions